Glucos Viaflo Baxter (Glucose)

Glucos Viaflo Baxter is used in several clinical situations where intravenous fluid support or glucose supplementation is required.

• Fluid and electrolyte replacement for patients unable to take oral intake
• Treatment of hypoglycemia when rapid glucose restoration is needed
• Diluent for the reconstitution and administration of intravenous medications
• Maintenance of blood glucose levels during surgical procedures
• Nutritional support in pediatric or neonatal care when oral feeding is not feasible

Adverse reactions to Glucos Viaflo Baxter are generally related to the intravenous administration of a glucose solution.

Common

• Mild local irritation or phlebitis at the infusion site
• Transient hyperglycemia, especially in patients with impaired glucose tolerance
• Electrolyte disturbances such as mild hyponatremia
• Nausea or mild gastrointestinal discomfort
• Low-grade fever or chills during infusion

Serious

• Severe hyperglycemia leading to osmotic diuresis
• Anaphylactic or severe allergic reactions
• Hemolysis in patients with glucose-6-phosphate dehydrogenase deficiency
• Metabolic acidosis from rapid glucose metabolism
• Fluid overload causing pulmonary edema or heart failure exacerbation

When using Glucos Viaflo Baxter, clinicians should consider several safety measures to minimize risks.

• Verify patient’s blood glucose level before and during infusion to avoid excessive hyperglycemia
• Adjust infusion rate in patients with renal or cardiac insufficiency to prevent fluid overload
• Use caution in individuals with known glucose intolerance, diabetes, or metabolic disorders
• Monitor electrolytes, especially sodium and potassium, during prolonged therapy
• Ensure aseptic technique to reduce the risk of catheter‑related infections
• Review compatibility with other intravenous drugs before co‑administration

Glucos Viaflo Baxter may interact with other agents administered intravenously or affect systemic metabolism.

Avoid

• Concurrent infusion of high‑dose insulin without appropriate glucose monitoring
• Mixing with calcium‑containing solutions that may precipitate
• Co‑administration with drugs that cause rapid shifts in fluid balance, such as diuretics, without monitoring

Use with caution

• Concurrent use of other hyperosmolar solutions (e.g., mannitol) that could exacerbate fluid shifts
• Administration alongside catecholamines that may increase glucose production
• Use with medications that have a narrow therapeutic index and are sensitive to changes in plasma glucose (e.g., certain antiepileptics)
• Patients receiving total parenteral nutrition, requiring careful electrolyte and glucose balance